MIRM
Mirum Pharmaceuticals Inc
Price:  
51.93 
USD
Volume:  
255,993.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MIRM Relative Valuation

-139.8%
Upside

As of 2025-07-19, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (20.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 51.93 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -139.8%.

The range of the Relative Valuation is (15.83) - (28.86) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.6x - 18.5x 13.0x
Forward P/E multiples 10.1x - 21.0x 13.5x
Fair Price (15.83) - (28.86) (20.69)
Upside -130.5% - -155.6% -139.8%
51.93 USD
Stock Price
(20.69) USD
Fair Price

MIRM Relative Valuation - Historical P/E Data

Date P/E
2025-07-16 -33.81
2025-07-15 -33.29
2025-07-14 -34.12
2025-07-11 -33.72
2025-07-10 -33.95
2025-07-09 -34.24
2025-07-08 -32.19
2025-07-07 -32.32
2025-07-03 -32.21
2025-07-02 -31.44
2025-07-01 -30.99
2025-06-30 -32.59
2025-06-27 -32.72
2025-06-26 -32.38
2025-06-25 -32.10
2025-06-24 -32.73
2025-06-23 -32.20
2025-06-20 -32.24
2025-06-18 -32.53
2025-06-17 -32.47
2025-06-16 -32.29
2025-06-13 -31.78
2025-06-12 -31.39
2025-06-11 -31.03
2025-06-10 -31.37
2025-06-09 -30.13
2025-06-06 -29.70
2025-06-05 -28.59
2025-06-04 -28.57
2025-06-03 -29.00
2025-06-02 -29.44
2025-05-30 -28.47
2025-05-29 -28.18
2025-05-28 -28.01
2025-05-27 -28.10
2025-05-23 -28.18
2025-05-22 -28.21
2025-05-21 -28.38
2025-05-20 -29.04
2025-05-19 -28.75
2025-05-16 -28.83
2025-05-15 -29.00
2025-05-14 -28.43
2025-05-13 -28.99
2025-05-12 -29.18
2025-05-09 -28.35
2025-05-08 -28.97
2025-05-07 -26.40
2025-05-06 -26.26
2025-05-05 -28.27